• Corpus ID: 36575115

Measuring the effects of genetic testing: studies on thrombophilia, sickle cell trait, recurrent miscarriage and male subfertility

@inproceedings{Vansenne2011MeasuringTE,
  title={Measuring the effects of genetic testing: studies on thrombophilia, sickle cell trait, recurrent miscarriage and male subfertility},
  author={Fleur Vansenne},
  year={2011}
}
Fleur Vansenne onderzocht de psychosociale effecten van het genetisch testen op dragerschap van sikkelcelziekte. Ze onderzocht ook de effecten van genetisch testen op trombofilie, herhaalde miskramen en mannelijke subfertiliteit (verminderde vruchtbaarheid). De patienten in het onderzoek waren vooraf niet genetisch gecounseld. Uit het onderzoek van Vansenne blijkt dat de wetenschappelijke onderbouwing van het nut van sommige tests soms te wensen over laat. Ook kennis over de ziekte en de… 
pure.uva.nl

References

SHOWING 1-10 OF 181 REFERENCES
No association between the common MTHFR 677C->T polymorphism and venous thrombosis: results from the MEGA study.
TLDR
In a single large study, MTHFR 677C-->T was not associated with the risk of venous thrombosis, and the narrow confidence interval excludes even a small effect.
Pros and cons of thrombophilia testing: cons
  • S. Machin
  • Medicine
    Journal of thrombosis and haemostasis : JTH
  • 2003
TLDR
Widespread thrombophilia screening has been advocated in many clinical situations but particularly in women prior to starting a combined oral contraceptive pill or hormone replacement therapy and also during pregnancy, but whether indiscriminate generalized screening and the routine clinical practice of testing is necessary or helpful is considered.
Social aspects of genetic testing for factor V Leiden mutation in healthy individuals and their importance for daily practice.
Safety issues in assisted reproduction technology: should ICSI patients have genetic testing before treatment? A practical proposition to help patient information.
TLDR
It is proposed that men with very low sperm counts considering ICSI should always be informed of the possibility of genetic testing and reassurance that a decision to test or not to test, or the subsequent test results will not be used as a reason for withholding treatment.
Imparting carrier status results detected by universal newborn screening for sickle cell and cystic fibrosis in England: a qualitative study of current practice and policy challenges
TLDR
Differing models for communicating carrier results raise concerns about equity and clinical governance and timely and more detailed guidance on protocols with clarification of existing recommendations is needed.
Are genetic tests exceptional? Lessons from a qualitative study on thrombophilia.
Pros and cons of thrombophilia testing: pros
  • I. Martinelli
  • Medicine, Biology
    Journal of thrombosis and haemostasis : JTH
  • 2003
TLDR
Thrombophilia screening helps to decide on the usefulness of primary prophylaxis in the presence of transient risk factors in asymptomatic relatives of thrombosis patients diagnosed with thromBophilia.
Ethical aspects of neonatal screening for sickle cell disease in Western European countries.
UNLABELLED Sickle cell disease raises some important ethical questions regarding neonatal screening in Western European countries such as France, England or Belgium, which have already introduced…
Attitudes toward genetic testing for thrombophilia in asymptomatic members of a large family with heritable protein C deficiency
TLDR
There seem to be few negative psychological consequences of knowing that one is at an increased risk for venous thrombosis, except in vulnerable individuals.
Patients' understanding of genetic susceptibility testing in mainstream medicine: qualitative study on thrombophilia
TLDR
Policy visions of clinicians and patients in mainstream medicine seeking and using genetic information at their own initiative may not be realistic and patients need more direct support in making sense of genetic information, if this information is to bring the anticipated health benefits, and not fuel health inequalities or create ethical problems.
...
1
2
3
4
5
...